| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |